Published: Apr 10, 2026
Written by Klarity Editorial Team
Published: Apr 10, 2026

If you’re struggling with Binge Eating Disorder (BED), you’re not alone—and you might be wondering whether you can access treatment without visiting a doctor’s office in person. The good news: yes, you can receive evaluation and prescription medication for BED through telehealth in most of the United States. In fact, telehealth has become a safe, legal, and increasingly common way to get help for binge eating and related mental health conditions.
Whether you’re curious about medications like Topamax or Wellbutrin, concerned about privacy, or simply trying to understand what’s legal in your state, this guide will walk you through everything you need to know about telehealth prescriptions for Binge Eating Disorder in 2025 and 2026.
Before diving into how telehealth works, let’s clarify what Binge Eating Disorder actually is. BED is a serious eating disorder characterized by recurrent episodes of eating large quantities of food in a short period—typically within two hours—while feeling a loss of control. Unlike bulimia, people with BED don’t regularly purge afterward.
According to the DSM-5 diagnostic criteria, BED involves:
If this sounds familiar, it’s important to know that BED is a recognized medical condition that responds to treatment—and telehealth can be an excellent gateway to getting that help.
Here’s the critical point that often confuses people: federal law does not restrict telehealth prescribing for non-controlled medications like those commonly used to treat Binge Eating Disorder.
The Ryan Haight Act, which many people have heard about, only applies to controlled substances—medications with abuse potential that the DEA regulates (like ADHD stimulants or opioids). The medications most often prescribed for BED via telehealth—topiramate (Topamax) and bupropion (Wellbutrin)—are not controlled substances, meaning they fall outside these restrictions entirely.
During the COVID-19 pandemic, the DEA temporarily relaxed rules even for controlled substances, and those flexibilities have been extended through December 31, 2026. However, for the non-controlled medications used to treat BED, there never was a federal barrier to telehealth prescribing in the first place.
This means that across the entire United States, healthcare providers licensed in your state can evaluate you via video visit and prescribe appropriate BED medications without requiring an in-person exam first.
While federal law permits telehealth prescribing for BED medications, individual states have their own additional rules. The good news is that most states have embraced telehealth and made it easier, not harder, to access care remotely.
California, Delaware, Florida, New York, Texas, Michigan, Wisconsin, and South Carolina all allow prescribers to evaluate and treat patients entirely via telehealth for non-controlled medications. In these states, your initial evaluation can happen through a video visit, and you can continue treatment without ever needing to visit an office.
California has been particularly progressive, with 2025 legislation (AB 1503) explicitly clarifying that even asynchronous telehealth—where you fill out detailed questionnaires and a provider reviews them later—can count as an appropriate examination for prescribing when it meets the standard of care.
A small number of states ask for periodic in-person contact if you’re receiving ongoing telehealth care:
Alabama requires that if you have more than four telehealth visits for the same condition within 12 months, you must be seen in person within that year. However, this can often be satisfied by seeing any healthcare provider (not necessarily the telehealth prescriber), making it quite flexible in practice.
Georgia requires an attempt at an annual in-person exam for continuing telemedicine relationships, though initial evaluations can be done via telehealth if the technology allows for an equivalent standard of care.
New Hampshire passed updated legislation in 2025 allowing telehealth prescribing even for controlled substances (with annual in-person follow-up), but for non-controlled BED medications, the rules are even more relaxed.
These requirements are manageable for most patients and shouldn’t prevent you from starting treatment via telehealth.
You have several options when it comes to providers who can prescribe medications for Binge Eating Disorder through telehealth:
Medical doctors and doctors of osteopathy can prescribe BED medications in all 50 states via telehealth, assuming they’re licensed in your state. This is the most straightforward scenario.
Nurse Practitioners are increasingly able to practice independently, which means they can evaluate and prescribe medications without physician oversight. As of 2025, 34 states plus Washington D.C. grant NPs full practice authority. Recent additions include Wisconsin and Michigan, which both passed legislation in 2023-2025 expanding NP independence.
In states with full practice authority (like California, New York, Delaware, New Hampshire, Michigan, and Wisconsin), an NP can be your primary telehealth provider for BED treatment, conducting evaluations and prescribing medications independently.
In other states (including Texas, Florida, Georgia, and Alabama), NPs must work under collaborative agreements with physicians. This doesn’t mean you need to see the physician—it’s a regulatory requirement that happens behind the scenes. The NP can still evaluate you and prescribe your medication; they just need a formal relationship with a supervising doctor.
PAs can also prescribe medications for BED under the supervision or collaboration of a physician in all states. Like NPs in collaborative states, PAs provide excellent care—you may just see multiple provider names on your prescription due to regulatory requirements.
At Klarity Health, patients connect with licensed providers—including psychiatrists, psychiatric nurse practitioners, and physician assistants—who are experienced in treating eating disorders and mental health conditions via telehealth, ensuring you receive care from qualified professionals regardless of your location.
While only one medication (lisdexamfetamine/Vyvanse, a controlled stimulant) has FDA approval specifically for Binge Eating Disorder, several non-controlled medications are commonly prescribed ‘off-label’ with good clinical evidence supporting their use.
Topiramate is an anticonvulsant medication originally approved for seizures and migraine prevention. At lower doses, it’s frequently used off-label for BED because it can help reduce the frequency of binge episodes and support impulse control.
Key facts about topiramate for BED:
Bupropion is an atypical antidepressant also approved for smoking cessation. It’s used off-label for BED because it can help reduce binge frequency and address co-occurring depression, which is common in people with eating disorders.
Key facts about bupropion for BED:
You might have heard that Vyvanse (lisdexamfetamine) is FDA-approved for BED. That’s true—but there’s a catch. Vyvanse is a Schedule II controlled substance (an amphetamine-based stimulant), which means the strict DEA telehealth rules do apply to it.
Under current temporary federal rules (extended through December 2026), some telehealth providers can prescribe controlled substances, but many choose not to due to regulatory complexity and abuse concerns. Most telehealth platforms focused on BED treatment stick to non-controlled options like topiramate and bupropion for this reason.
If you’re interested in Vyvanse, you’ll likely need an in-person evaluation with a psychiatrist or eating disorder specialist, at least initially. However, the non-controlled alternatives available via telehealth can be quite effective.
If you’re concerned about receiving a medication that’s not FDA-approved specifically for BED, you’re not alone—but off-label prescribing is both legal and extremely common in medicine.
‘Off-label’ simply means a doctor is prescribing a medication for a condition other than what the FDA originally approved it for. This happens all the time, especially in psychiatry and eating disorder treatment, because:
For BED specifically, both topiramate and bupropion have research supporting their use, and they’re recommended in clinical guidelines from eating disorder specialists. Your telehealth provider should explain why they’re recommending a particular medication, discuss the evidence supporting its use for BED, and obtain your informed consent for off-label treatment.
This is standard medical practice, not a red flag—as long as your provider is transparent about it.
When you pursue telehealth treatment for Binge Eating Disorder, you should expect a thorough evaluation—not a rubber-stamp prescription service.
A legitimate telehealth evaluation for BED typically includes:
This evaluation often takes 30-45 minutes for an initial visit—if a service offers prescriptions after a 5-minute questionnaire, that’s a red flag.
Don’t be surprised when your telehealth provider verifies your identity and current location. This isn’t about distrust—it’s a legal requirement in many states to ensure:
You’ll be asked to sign a telehealth consent form explaining:
Take time to read this document and ask questions.
A good provider will discuss multiple treatment approaches, not just medication. For BED, the gold standard often includes:
While you can absolutely start with medication via telehealth, be wary of any provider who only offers pills and doesn’t at least mention therapy or other interventions.
Many patients wonder if their telehealth provider will ‘look them up’ in a government database before prescribing. Here’s what you need to know about Prescription Monitoring Programs (PMPs):
Every state maintains a Prescription Drug Monitoring Program—a database tracking prescriptions for controlled substances. These were created to prevent ‘doctor shopping’ (getting the same controlled medication from multiple providers) and identify potential prescription drug misuse.
In most cases, no. Because topiramate and bupropion are not controlled substances, most states do not require providers to check the PMP before prescribing them. The mandatory PMP lookup laws typically apply only to opioids, benzodiazepines, stimulants, and other controlled medications.
That said, your telehealth provider may choose to review your medication history as a safety precaution—for example, to ensure you’re not already taking another form of bupropion under a different brand name, or to check for potential drug interactions. This is considered good clinical practice even when not legally mandated.
Some states (like Florida and Texas) have stricter PMP requirements that mandate checks before prescribing any medication with potential for misuse, but this rarely extends to the non-controlled medications used for BED. Your provider will follow their state’s rules automatically—you don’t need to worry about this on your end.
One advantage of non-controlled medications is flexibility with refills and ongoing care.
Because topiramate and bupropion aren’t controlled substances, providers can often write prescriptions with multiple refills—sometimes up to a year’s worth. However, expect your provider to:
While some states require periodic in-person visits for long-term telehealth relationships, you should expect regular follow-up appointments regardless:
These follow-ups can usually be conducted via telehealth video visits, making ongoing care convenient.
Klarity Health offers flexible scheduling and regular check-ins with your provider, ensuring continuity of care while respecting your busy schedule—all from the comfort of your home.
The pandemic-era telehealth boom brought both opportunities and challenges. While most telehealth platforms operate ethically, there have been high-profile cases of unsafe prescribing (notably a 2024 case involving an ADHD telehealth company whose executives were indicted for unsafe Adderall prescribing that contributed to medication shortages).
Avoid telehealth services that:
Look for services that:
Klarity Health maintains strict clinical protocols, employs only state-licensed providers, and offers transparent pricing—whether you’re using insurance or paying cash—ensuring you receive safe, ethical care that meets the highest standards.
Most insurance plans now cover telehealth visits at the same rate as in-person visits, thanks to policies adopted during the pandemic and extended in many states. However, coverage specifics vary:
Insurance coverage for topiramate and bupropion is generally good because:
Typical copays range from $10-50 for a month’s supply, though this varies by plan. If you don’t have insurance or your plan doesn’t cover the medication, cash prices for generics are often reasonable—frequently $20-60 per month.
Many patients choose cash-pay telehealth services for convenience, privacy, or because they don’t have insurance. Transparent telehealth platforms typically charge:
At Klarity Health, we accept both insurance and cash payments, with upfront pricing so you know exactly what you’ll pay—no surprise bills. Our mission is to make mental healthcare, including eating disorder treatment, accessible and affordable.
While telehealth works well for many people with Binge Eating Disorder, it’s not appropriate for everyone. You may need in-person care if:
Some patients do better with in-person, intensive eating disorder programs that offer:
Telehealth can complement this care but may not replace it for severe cases.
A reputable telehealth provider will recognize when you need a higher level of care and refer you appropriately—this is a sign of quality, not rejection.
While this guide focuses on prescriptions via telehealth, it’s crucial to understand that medication is most effective when combined with therapy for BED.
Cognitive Behavioral Therapy (CBT) adapted for eating disorders (called CBT-E) is considered the gold standard psychotherapy for BED. It helps you:
Many telehealth platforms (including Klarity Health) offer therapy as well as medication management, allowing you to address BED comprehensively.
Think of medication as one tool in your recovery toolbox—therapy and other supports are equally important.
The regulatory landscape for telehealth continues to evolve. Here’s what’s happened recently and what to watch for:
In late 2025, the DEA extended the COVID-19 public health emergency telehealth prescribing flexibilities through December 31, 2026. While this primarily affects controlled substances (not the BED medications we’ve discussed), it signals continued federal support for telehealth access.
The DEA is still working on permanent rules for telehealth prescribing of controlled substances. These are expected by late 2026 but won’t affect non-controlled medications like topiramate or bupropion.
Several states made telehealth more accessible in 2025:
New York moved in a slightly more restrictive direction for controlled substances, requiring in-person visits before prescribing them via telehealth (once federal waivers end). However, this doesn’t affect non-controlled BED medications.
The overall trend is toward permanent, expanded telehealth access. While there’s been appropriate tightening around controlled substance prescribing (to prevent the kind of abuses that made headlines), access to non-controlled medications for conditions like BED remains strong and is likely to stay that way.
You can feel confident that telehealth for BED is not a temporary workaround—it’s becoming a permanent part of the healthcare landscape.
Ready to take the next step? Here’s how to make your first telehealth visit as smooth and productive as possible:
Still on the fence about whether telehealth is right for you? Consider these advantages:
At Klarity Health, we’ve made telehealth mental healthcare accessible to thousands of patients struggling with eating disorders, anxiety, depression, and ADHD—connecting you with caring, qualified providers who understand your challenges and respect your time.
If you’re living with Binge Eating Disorder, you already know how isolating and overwhelming it can feel. The shame, the secrecy, the sense of being out of control—these are all part of the disorder, not reflections of your character or willpower.
Seeking help is an act of courage, and telehealth makes that first step more accessible than ever before.
You don’t need to have your eating ‘under control’ before reaching out. You don’t need to hit rock bottom. You don’t need to wait until you can arrange in-person appointments. You can start right where you are—today, from your home, in your pajamas if you want.
Medications like topiramate and bupropion aren’t magic bullets, but for many people with BED, they’re powerful tools that reduce binge frequency, ease distress, and create space for the deeper work of therapy and recovery. Combined with evidence-based therapy and support, medication can help you break free from the cycle of binge eating and build a healthier relationship with food and your body.
The path to recovery starts with a conversation. And in 2025, that conversation can happen via telehealth—safely, legally, and effectively.
If you’re ready to explore telehealth treatment for Binge Eating Disorder:
Klarity Health is here to support you on that journey. Our experienced providers understand eating disorders and can help you access evidence-based treatment—including medication management and therapy—through convenient, affordable telehealth visits. We accept most major insurance plans and offer transparent cash pricing, with appointments often available within days, not weeks.
You don’t have to struggle alone. Help is available, accessible, and just a video call away.
Can I get BED medication prescribed online without ever seeing a doctor in person?
Yes, in most states you can receive an initial evaluation and prescription for non-controlled BED medications (like topiramate or bupropion) entirely via telehealth without an in-person visit. A few states (Alabama, Georgia, New Hampshire) require periodic in-person follow-up for long-term telehealth relationships, but you can typically start treatment remotely.
Is it legal to prescribe medication for eating disorders via video visit?
Absolutely. Federal law does not restrict telehealth prescribing for non-controlled medications, and most states have permanently adopted telehealth-friendly policies. As long as your provider is licensed in your state and follows appropriate clinical standards, prescribing BED medications via telehealth is completely legal.
Will my insurance cover telehealth visits for binge eating disorder?
Most insurance plans now cover telehealth visits at the same rate as in-person visits. Medicare has extended telehealth coverage through at least 2026, and most commercial plans and state Medicaid programs cover mental health telehealth services. Check with your specific plan to confirm coverage.
How much does telehealth treatment for BED cost without insurance?
Cash-pay costs vary by platform but typically range from $99-199 for initial evaluations and $59-99 for follow-up visits. Medications like generic topiramate and bupropion usually cost $20-60 per month at pharmacies. Many patients find this affordable compared to in-person specialist visits.
What medications can be prescribed via telehealth for binge eating?
Non-controlled medications like topiramate (Topamax) and bupropion (Wellbutrin) can be prescribed via telehealth in all states. The FDA-approved medication for BED, lisdexamfetamine (Vyvanse), is a controlled substance and has stricter telehealth prescribing rules—many platforms don’t prescribe it remotely.
Do I need to see a psychiatrist, or can a nurse practitioner prescribe BED medication?
Both can prescribe BED medications via telehealth. In 34+ states, nurse practitioners have full practice authority and can prescribe independently. In other states, NPs work under collaborative agreements with physicians but can still evaluate you and prescribe medications—you likely won’t need to see the supervising physician.
How long does a telehealth evaluation for BED take?
A thorough initial evaluation typically takes 30-45 minutes. If a platform offers prescriptions after just a few questions or a 5-minute assessment, that’s a red flag—comprehensive evaluations are necessary for safe, effective treatment.
Will my telehealth provider check a prescription monitoring database?
For non-controlled medications like topiramate and bupropion, most states don’t require providers to check prescription monitoring programs (PMPs). Your provider may review your medication history as a safety measure, but it’s not usually mandated by law for these medications.
Can I continue telehealth treatment if I move to a different state?
This depends on your provider’s licensing. Most telehealth providers are licensed in multiple states but not all 50. If you move, you may need to transition to a provider licensed in your new state, or your current provider may be able to obtain licensure there. Check before relocating if continuity is important to you.
What if I need emergency care while being treated via telehealth?
Telehealth providers cannot provide immediate in-person emergency care. If you experience a psychiatric emergency (suicidal thoughts, severe medication reaction), you should call 911, go to your nearest emergency room, or call the 988 Suicide and Crisis Lifeline. Your telehealth platform should have clear emergency protocols explained during your consent process.
Verified as of: January 4, 2026
DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine. Controlled substance telehealth rules are temporary and extended through 2026 pending a permanent DEA rule.
States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.
Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.
Flagged for follow-up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.
U.S. Department of Health and Human Services. (2026, January 2). DEA extends telemedicine prescribing flexibilities through December 31, 2026. HHS.gov. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard, Mullin, Richter & Hampton LLP. (2025,
Find the right provider for your needs — select your state to find expert care near you.